Strongbridge Biopharma

$3.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-5.87%) Today
-$0.01 (-0.31%) As of 1:01 PM UTC after-hours

Why Robinhood?

You can buy or sell SBBP and other stocks, options, and ETFs commission-free!

About SBBP

Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded on May 26, 2015 and is headquartered in Trevose, PA. The listed name for SBBP is Strongbridge Biopharma plc Ordinary Shares.

CEO
John H. Johnson
Employees
71
Headquarters
Trevose, Pennsylvania
Founded
2015
Market Cap
210.16M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.85M
High Today
$3.42
Low Today
$3.21
Open Price
$3.33
Volume
630.36K
52 Week High
$4.63
52 Week Low
$1.50

SBBP Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 3, Pre-Market

You May Also Like

POWW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure